Advertisement

Purpose:

We assessed the oncological outcome of penile conserving surgery and identified parameters predicting local recurrence, including resection margins.

Materials and Methods:

A total of 179 patients with invasive penile cancer treated with organ sparing surgery at a tertiary center between 2002 and 2010 fulfilled our study criteria. Demographic, histopathological, management and followup data were recorded in a prospective database. Local, regional and distant recurrence rates, time to recurrence and survival rates were calculated. Survival analysis was performed by the Kaplan-Meier method. Multivariate analysis was used to identify predictors of local recurrence.

Results:

Mean followup was 42.8 months (range 4 to 107). Local, regional and distant metastatic recurrence developed in 16 (8.9%), 19 (10.6%) and 9 patients (5.0%) at a mean of 26.1, 26.8 and 11.7 months, respectively. The 5-year disease specific survival rate after recurrence was 54.7% (95% CI 46.1–63.3). For patients with isolated local recurrence the 5-year disease specific survival rate was 91.7% compared to 38.4% for those with regional recurrence. The overall 5-year local recurrence-free rate was 86.3% (95% CI 82.6–90.4). Tumor grade (p = 0.003), stage (p = 0.021) and lymphovascular invasion (p = 0.014) were identified as predictors of local recurrence on multivariate analysis.

Conclusions:

Penile conserving surgery is oncologically safe and a surgical excision margin of less than 5 mm is adequate. Higher local recurrence rates are associated with lymphovascular invasion, and higher tumor stage and grade. Local recurrence has no negative impact on long-term survival.

References

  • 1 : EAU guidelines on penile cancer. Eur Urol2002; 42: 199. Google Scholar
  • 2 : Epidemiology and natural history of penile cancer. Urology2010; 76: S2. Google Scholar
  • 3 : New developments in the treatment of localized penile cancer. Urology2010; 76: S36. Google Scholar
  • 4 : Quality of life in patients treated for penile cancer: A follow-up study. Br J Urol1994; 74: 652. Google Scholar
  • 5 : Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer. BMC Urol2009; 9: 8. Google Scholar
  • 6 : Reconstructive surgery for invasive squamous carcinoma of the glans penis. Eur Urol2007; 52: 1179. Google Scholar
  • 7 : What surgical resection margins are required to achieve oncological control in men with primary penile cancer?. BJU Int2005; 96: 1040. Google Scholar
  • 8 : Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol2011; 59: 142. Google Scholar
  • 9 : Long-term follow-up after laser therapy for penile carcinoma. Urology2007; 69: 759. Google Scholar
  • 10 : Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol2008; 54: 875. Google Scholar
  • 11 : Treatment of penile carcinoma: to cut or not to cut. Int J Radiat Oncol Biol Phys2006; 66: 674. Google Scholar
  • 12 : Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys2009; 74: 1150. Google Scholar
  • 13 : Interstitial brachytherapy for penile cancer: an alternative to amputation. J Urol2002; 167: 506. LinkGoogle Scholar
  • 14 : A retrospective analysis of 82 cases of cancer of the penis. Br J Urol1996; 77: 883. Google Scholar
  • 15 : Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J Urol2003; 169: 500. LinkGoogle Scholar
  • 16 : Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol2006; 176: 575. LinkGoogle Scholar
  • 17 : Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol2008; 54: 161. Google Scholar
  • 18 : Long-term outcome of excisional organ sparing surgery for carcinoma of the penis. J Urol2011; 186: 1303. LinkGoogle Scholar
  • 19 : Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases. Am J Surg Pathol2009; 33: 1299. Google Scholar
  • 20 : Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute. J Urol2008; 180: 1354. LinkGoogle Scholar
  • 21 : Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol2010; 58: 742. Google Scholar
  • 22 : Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-Oncologico del Nord Est (Northeast Uro-Oncological Group) Penile Cancer data base data. Cancer2005; 103: 2507. Google Scholar

Department of Andrology, Institute of Urology, University College London Hospitals, London, United Kingdom

Advertisement